Riverview Trust Company’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-139
| Closed | -$69.2K | – | 549 |
|
|
2025
Q1 | $69.2K | Buy |
139
+74
| +114% | +$36.8K | 0.07% | 183 |
|
|
2024
Q4 | $33.8K | Sell |
65
-151
| -70% | -$78.6K | 0.03% | 285 |
|
|
2024
Q3 | $134K | Buy |
216
+7
| +3% | +$4.33K | 0.12% | 130 |
|
|
2024
Q2 | $116K | Buy |
209
+70
| +50% | +$38.7K | 0.11% | 143 |
|
|
2024
Q1 | $80.8K | Buy |
+139
| New | +$80.8K | 0.06% | 186 |
|
|
2023
Q4 | – | Sell |
-264
| Closed | -$134K | – | 581 |
|
|
2023
Q3 | $134K | Sell |
264
-120
| -31% | -$60.7K | 0.12% | 122 |
|
|
2023
Q2 | $200K | Hold |
384
| – | – | 0.18% | 89 |
|
|
2023
Q1 | $221K | Hold |
384
| – | – | 0.2% | 84 |
|
|
2022
Q4 | $211K | Sell |
384
-439
| -53% | -$241K | 0.2% | 85 |
|
|
2022
Q3 | $417K | Sell |
823
-11
| -1% | -$5.57K | 0.4% | 50 |
|
|
2022
Q2 | $453K | Buy |
834
+113
| +16% | +$61.4K | 0.39% | 51 |
|
|
2022
Q1 | $426K | Buy |
721
+278
| +63% | +$164K | 0.32% | 53 |
|
|
2021
Q4 | $296 | Hold |
443
| – | – | 0.17% | 70 |
|
|
2021
Q3 | $253K | Hold |
443
| – | – | 0.27% | 70 |
|
|
2021
Q2 | $223K | Hold |
443
| – | – | 0.24% | 77 |
|
|
2021
Q1 | $202K | Hold |
443
| – | – | 0.23% | 79 |
|
|
2020
Q4 | $206K | Hold |
443
| – | – | 0.23% | 76 |
|
|
2020
Q3 | $196K | Sell |
443
-589
| -57% | -$261K | 0.23% | 76 |
|
|
2020
Q2 | $374K | Hold |
1,032
| – | – | 0.36% | 53 |
|
|
2020
Q1 | $293K | Sell |
1,032
-403
| -28% | -$114K | 0.28% | 65 |
|
|
2019
Q4 | $466K | Hold |
1,435
| – | – | 0.31% | 59 |
|
|
2019
Q3 | $418K | Hold |
1,435
| – | – | 0.29% | 67 |
|
|
2019
Q2 | $421K | Hold |
1,435
| – | – | 0.3% | 65 |
|
|
2019
Q1 | $393K | Hold |
1,435
| – | – | 0.3% | 68 |
|
|
2018
Q4 | $321K | Buy |
+1,435
| New | +$321K | 0.25% | 72 |
|